
Bindal Pharma LLP
About Bindal Pharma LLP
Data last updated:
Bindal Pharma LLP is a limited liability partnership (LLP) based in Raisen, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Gwalior, under LLPIN AAD-8723. Its GSTIN is 23AAPFB0524M1ZI (Madhya Pradesh).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Jagdeesh Baboo Bindal and Pankaj Bindal.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No 116 B Sector A Industrial Area Mandideep, Raisen, Madhya Pradesh, India – 464551.
As per the financials filed for FY 2019, the LLP reported a revenue of ₹9.18 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net loss of ₹20.26 Lakh (net margin -220.6%) and EBITDA of ₹25.66 Lakh (EBITDA margin 279.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 116 B Sector A Industrial Area Mandideep, Raisen, Madhya Pradesh, India – 464551
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Bindal Pharma LLP FY 2025 filings available
Bindal Pharma LLP reported revenue of ₹9.18 Lakh (up 13% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Bindal Pharma LLP
Revenue rose 13% in the latest year. EBITDA rose 8% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Bindal Pharma LLP
| Statement of Account and Solvency | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | ₹9.18 Lakh | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | -₹20.26 Lakh | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Bindal Pharma LLP
| Statement of Account and Solvency | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | -220.6% | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Bindal Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Bindal Pharma LLP
Bindal Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdeesh Baboo Bindal | Designated Partner | 05 May 2015 | 11 Years 5 Months | Current |
| Pankaj Bindal | Designated Partner | 05 May 2015 | 11 Years 5 Months | Current |
Ownership and Shareholding of Bindal Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bindal Pharma LLP
Bindal Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bindal Pharma LLP
Employment history and EPFO contributions of people linked to Bindal Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bindal Pharma LLP
Bindal Pharma LLP has 2 designated partner changes on record since 2015: 2 appointments. The latest: Jagdeesh Baboo Bindal was appointed as Designated Partner on 05 May 2015.
Credit Ratings, Litigation & Regulatory Alerts for Bindal Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bindal Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bindal Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bindal Pharma LLP
Bindal Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAPFB0524M1ZI | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bindal Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bindal Pharma LLP
Bindal Pharma is an active limited liability partnership based in Raisen, Madhya Pradesh, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 2015 (11+ years old) and is registered under LLPIN AAD-8723.
Bindal Pharma reported revenue of ₹9.18 Lakh for FY 2019 (up 13% YoY).
Bindal Pharma has 2 current designated partners:
- Jagdeesh Baboo Bindal - Designated Partner
- Pankaj Bindal - Designated Partner
Bindal Pharma reported a net loss of ₹20.26 Lakh (net margin -220.6%) and EBITDA of ₹25.66 Lakh (EBITDA margin 279.4%) for FY 2019, as per its filed financial statements.
The GSTIN of Bindal Pharma is 23AAPFB0524M1ZI, registered in Madhya Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Bindal Pharma is AAD-8723. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Bindal Pharma was incorporated on 05 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
Jagdeesh Baboo Bindal was appointed as Designated Partner on 05 May 2015. Pankaj Bindal was appointed as Designated Partner on 05 May 2015.
The registered office of Bindal Pharma is at Plot No 116 B Sector A Industrial Area Mandideep, Raisen, Madhya Pradesh, India – 464551.
The total obligation of contribution is ₹1 Lakh.